Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer Research|June 24, 2011
Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapyPascale Hubert, Adèle Heitzmann, Sophie Viel, et al.
International Journal of Biological Macromolecules|April 15, 2021
Docetaxel in chitosan-based nanocapsules conjugated with an anti-Tn antigen mouse/human chimeric antibody as a promising targeting strategy of lung tumorsAnalía Castro, Nora Berois, Antonio Malanga, et al.
Leukemia & Lymphoma|November 29, 2014
Dissecting chronic lymphocytic leukemia microenvironment signals in patients with unmutated disease: microRNA-22 regulates phosphatase and tensin homolog/AKT/FOXO1 pathway in proliferative leukemic cellsFlorencia Palacios, Daniel Prieto, Cecilia Abreu, et al.
Plos One|May 15, 2014
Potent and specific inhibition of glycosidases by small artificial binding proteins (affitins)Agustín Correa, Sabino Pacheco, Ariel E Mechaly, et al.
Blood|December 14, 2004
Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chainsFrançoise Vuillier, Gérard Dumas, Christian Magnac, et al.
British Journal of Haematology|January 25, 2003
Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemiaFrançoise Vuillier, Karim Maloum, Elaine K Thomas, et al.
British Journal of Haematology|April 12, 2012
Search for an aetiological virus candidate in chronic lymphocytic leukaemia by extensive transcriptome analysisNatalia Rego, Sergio Bianchi, Pilar Moreno, et al.
Leukemia & Lymphoma|April 26, 2013
Methylation status regulates lipoprotein lipase expression in chronic lymphocytic leukemiaCecilia Abreu, Pilar Moreno, Florencia Palacios, et al.
Blood|March 18, 2010
High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL diseaseFlorencia Palacios, Pilar Moreno, Pablo Morande, et al.
Blood|March 1, 2019
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemiaPablo Elías Morande, Mariela Sivina, Angimar Uriepero, et al.
Pageof 5